Now Is Not The Time To Wait
One of the most common things we hear from patients is:
"My doctor said my labs were normal."
Yet the person sitting in front of us is exhausted, struggling to lose weight, experiencing brain fog, dealing with hair loss, battling digestive issues, fighting chronic inflammation, or noticing that something simply does not feel right.
The reality is that "normal" and "optimal" are not always the same thing.
Many healthcare systems are designed to identify disease once it becomes significant enough to meet diagnostic criteria. While this approach is important for diagnosing illness, it can often miss opportunities to recognize dysfunction much earlier in the process and allow the patient to address dysfunction before it becomes disease.
At our clinic, we believe there is tremendous value in paying attention to trends, borderline results, and subtle shifts in laboratory markers before they progress into more serious problems.
The Difference Between Disease Detection and Health Optimization
Traditional reference ranges are created by measuring large populations and determining where most people's values fall.
The important question becomes: How healthy is the population being used to establish those ranges?
In the United States, rates of obesity, insulin resistance, metabolic syndrome, cardiovascular disease, autoimmune conditions, and chronic inflammation continue to rise. Current estimates suggest that the majority of American adults have at least one marker of metabolic dysfunction.
If a population is becoming increasingly unhealthy, then the "normal" range may not necessarily represent optimal physiology.
A laboratory value can fall within the reference range while still indicating that something is beginning to move in the wrong direction.
This does not mean every slightly abnormal result requires treatment. But it does mean that trends deserve attention.
Health Problems Rarely Appear Overnight
Most chronic diseases develop gradually.
Insulin resistance develops years before Type 2 diabetes.
Iron deficiency often develops long before anemia.
Thyroid dysfunction may produce symptoms before laboratory values cross diagnostic thresholds.
Inflammation can be present for years before it manifests as autoimmune disease, cardiovascular disease, or chronic pain.
The body usually gives subtle signals long before a diagnosis is made.
Laboratory testing often provides an opportunity to see those signals earlier.
Why We Pay Attention to Borderline Values
Imagine two patients.
Patient A has a ferritin level of 14 ng/mL and feels fatigued, experiences hair shedding, struggles with exercise tolerance, and has heavy menstrual cycles.
Patient B has a ferritin level of 5 ng/mL and severe anemia.
Most healthcare systems will focus on Patient B because the deficiency has become severe.
However, Patient A is already experiencing the consequences of depleted iron stores.
Waiting until the laboratory value becomes dramatically abnormal often means waiting until symptoms become significantly worse.
The same principle applies across many areas of health:
Fasting insulin trending upward
Hemoglobin A1C slowly increasing each year
Rising inflammatory markers
Declining vitamin D levels
Changes in thyroid function
Progressive hormone imbalances
Worsening lipid patterns
These trends often tell a story before disease becomes obvious.
The A1C Example
Hemoglobin A1C is a useful marker because it reflects average blood glucose over approximately three months.
Many patients assume that if their A1C falls within the laboratory reference range, there is nothing to worry about.
However, research has shown that metabolic dysfunction often begins years before someone meets criteria for diabetes.
Blood sugar regulation exists on a spectrum.
A person can have increasing insulin resistance, elevated fasting insulin levels, post-meal glucose spikes, weight gain, fatigue, and inflammation while maintaining an A1C that technically remains within the normal range.
By the time someone crosses into the diabetic range, the underlying process has frequently been developing for years.
This is why many preventative and functional medicine practitioners look beyond a single number and evaluate the broader metabolic picture, including fasting insulin, triglycerides, HDL cholesterol, body composition, inflammatory markers, and clinical symptoms.
Looking at the Entire Story
Lab values should never be interpreted in isolation.
A slightly elevated marker in a healthy individual may mean very little.
The exact same marker paired with fatigue, digestive symptoms, hormone changes, chronic inflammation, poor recovery, or family history may warrant a deeper investigation.
The goal is not to create fear around laboratory testing. The goal is to recognize opportunities. Every abnormal value began as a borderline value. Every severe deficiency was once a mild deficiency.
Every diagnosis started as a process.
Prevention Is More Powerful Than Crisis Management
Modern medicine performs miracles when treating advanced disease. But one of the greatest opportunities in healthcare is identifying dysfunction before it becomes disease. Paying attention to trends allows us to ask better questions:
Why is this changing?
What is driving this shift?
Can we address the root cause before more significant problems develop?
Rather than waiting for laboratory values to become severe enough to trigger a diagnosis, we believe patients deserve a proactive approach that seeks to understand what the body is communicating today.
Health is rarely lost overnight. More often, it changes gradually through small shifts that accumulate over time. The earlier we recognize those shifts, the greater our opportunity to support long-term health, vitality, and resilience.
Schedule your diagnostic consult today and begin getting to the bottom of how to optimize your health and individualize your plan forward.
References
O'Hearn M, Lauren BN, Wong JB, et al, Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018.", Journal of the American College of Cardiology. 2022;80(2):138-151.
Tsao CW, Aday AW, Almarzooq ZI, et al., "Heart Disease and Stroke Statistics 2023 Update.", Circulation. 2023;147:e93-e621.
Centers for Disease Control and Prevention (CDC)., National Diabetes Statistics Report.
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M., "Prediabetes: A High-Risk State for Diabetes Development.", The Lancet. 2012;379(9833):2279-2290.
Piché ME, Tchernof A, Després JP., "Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.", Circulation Research. 2020;126(11):1477-1500.
American Diabetes Association., Standards of Care in Diabetes., Updated annually.
Kraft JR., Diabetes Epidemic and You., Kraft Publishing; 2008.
Camaschella C., "Iron Deficiency.", Blood. 2019;133(1):30-39.
Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ., "Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side Effects in Adults.", PLoS One. 2015;10(2):e0117383.
Cappellini MD, Musallam KM, Taher AT., "Iron Deficiency Anaemia Revisited.", Journal of Internal Medicine. 2020;287(2):153-170.
Favrat B, Balck K, Breymann C, et al., "Evaluation of a Single Dose of Intravenous Iron in Fatigued, Iron-Deficient Women.", Blood. 2014;124(21):4858.
Siest G, Henny J, Grasbeck R, et al., "The Theory of Reference Values: An Unfinished Symphony.", Clinical Chemistry and Laboratory Medicine. 2013;51(1):47-64.
Fraser CG., Biological Variation: From Principles to Practice., AACC Press; 2001.
Baird GS., "Preanalytical Considerations in Blood Testing.", Biochemia Medica. 2013;23(1):49-62.
Roth GA, Mensah GA, Johnson CO, et al., "Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019.", Journal of the American College of Cardiology. 2020;76(25):2982-3021.
Collaborators GBDRF., "Global Burden of 87 Risk Factors in 204 Countries and Territories.", The Lancet. 2020;396(10258):1223-1249.
Egger G, Dixon J., "Beyond Obesity and Lifestyle: A Review of 21st Century Chronic Disease Determinants.", BioMed Research International. 2014;2014:731685.